ASX/Media Releases 2006-2009

Further Issue of Shortfall Shares and Options Jul 2, 2009
Section 708A Notice Jul 2, 2009
Appendix 3B Shortfall Allotment Jul 2, 2009
Expiry of Unlisted Options Jun 29, 2009
Further Issue of Shortfall Shares and Options Jun 12, 2009
Section 708A Notice Jun 12, 2009
Appendix 3B Shortfall Allotment Jun 12, 2009
Further Issue of Shortfall Shares and Options May 27, 2009
Section 708A Notice May 27, 2009
Appendix 3B Shortfall Allotment May 27, 2009
Benitec US Re-exam Update May 26, 2009
Issue of Shortfall Shares and Options Update May 18, 2009
Section 708A Notice May 18, 2009
Appendix 3B Shortfall Allotment May 18, 2009
Change in Substantial Holding May 12, 2009
Appendix 3B Completion of Rights Issue May 7, 2009
Completion of Rights Issue May 7, 2009
Benitec and City of Hope Human Trial Update May 6, 2009
Benitec US Re-exam Update May 5, 2009
Rights Issue - Notification of Shortfall May 4, 2009
Closing of Non-Renounceable Rights Issue Apr 30, 2009
Appendix 4C Quarterly Cash Flow Report Apr 30, 2009
Final Director's Interest Notice Apr 24, 2009
Director Resignation Apr 17, 2009
Appendix 3B Rights Issue Correction Apr 8, 2009
Company Contact Details Apr 6, 2009
Letter to Option Holders Apr 1, 2009
Non Renounceable Rights Issue Appendix 3B Apr 1, 2009
Non Renounceable Rights Issue Prospectus Apr 1, 2009
Benitec US Re-exam Update Mar 26, 2009
Movements in Benitec Shares and Options Mar 24, 2009
Benitec withdraws from renegotiations with CSIRO Mar 12, 2009
Half Year Report and Accounts Feb 27, 2009
Change in Substantial Holding Feb 10, 2009
City of Hope Human Trial Update Feb 9, 2009
Benitec confirms Capital Raising Feb 9, 2009
Appendix 4C - Quarterly Cash Flow Report Jan 30, 2009
Results of General Meeting Jan 7, 2009
Notice of General Meeting/Proxy Form Dec 8, 2008
City of Hope Human Trial Update Dec 8, 2008
US Patent Reexam Further Update Nov 28, 2008
US Patent Reexam Update Nov 21, 2008
Benitec Announces Prudent Cash Management Strategy Nov 20, 2008
Results of Meeting Nov 19, 2008
CEO Presentation to AGM Nov 19, 2008
Chairman's Address to Shareholders Nov 19, 2008
Change in Substantial Holding Nov 11, 2008
Benitec Double-Stranded Patent Granted in Singapore Nov 6, 2008
Appendix 3B - Share Placement Nov 6, 2008
Appendix 4C - Quarterly Cash Flow Report Oct 30, 2008
City of Hope Human Trial Update Oct 23, 2008
Private Placement Raises $1.97M Oct 22, 2008
Notice of Annual General Meeting and Proxy Form Oct 20, 2008
Graham Gene Silencing Patent Granted in New Zealand Oct 17, 2008
2008 Annual Report Oct 9, 2008
2008 Full Year Statutory Accounts Sep 26, 2008
Preliminary Final Report for Year ended 30 June 2008 Aug 29, 2008
Benitec Double-Stranded Patent Granted in New Zealand Aug 8, 2008
Appendix 4C - Quarterly Cash Flow Report Jul 22, 2008
Dr Zaia Update on HIV Lymphoma Study at ASGT Conference Jun 6, 2008
Benitec delays Capital Raising May 23, 2008
Proposed Underwritten Non-Renounceable Rights Issue May 16, 2008
Appendix 4C - Quarterly Cash Flow Report Apr 29, 2008
Benitec secures further rights to HIV Therapeutic Apr 29, 2008
Benitec wins in US Supreme Court Apr 22, 2008
US Patent Reexam Update Apr 21, 2008
Reinstatement to Official Quotation Apr 21, 2008
Suspension from Official Quotation Apr 16, 2008
Request for Voluntary Suspension Apr 16, 2008
Trading Halt Apr 14, 2008
Request for Trading Halt Apr 14, 2008
Exercise of Options Apr 11, 2008
Investor Update Apr 7, 2008
Dr Rossi presents update on HIV lymphoma study at Keystone meeting Mar 31, 2008
Expiry of Unlisted Options Mar 27, 2008
Benitec licensee’s Oncolys deal to commercialise Hep C drug Mar 13, 2008
Benitec US Reexam Update Mar 12, 2008
Change of Director's Interest Notice Mar 7, 2008
Changes to Unlisted Options and Appendix 3B Mar 6, 2008
Half Year Report and Accounts Feb 29, 2008
Final Director's Interest Notice Feb 26, 2008
Board Changes Feb 26, 2008
Corporate Flyer Jan-08 Feb 5, 2008
Presentation to BioPartnering North America Feb 5, 2008
Benitec at BioPartnering North America meeting Feb 5, 2008
Response to ASX Query Feb 5, 2008
Appendix 4C - Quarterly Cash Flow Report Jan 30, 2008
Ceasing to be a substantial shareholder Jan 10, 2008
Update on Nucleonics Request to US Supreme Court Jan 10, 2008
Response to ASX Query Jan 8, 2008
Benitec's Licensee confirms Hepatitis C deal with Pfizer Jan 8, 2008
Trading Halt Jan 8, 2008
Trading Halt Request Jan 8, 2008
Nucleonics files Request to US Supreme Court Jan 4, 2008
Company Response to ASX Price Query Jan 3, 2008
Change of Director's Interest Notice Dec 11, 2007
Change of Director's Interest Notice Dec 6, 2007
Change of Director's Interest Notice Dec 6, 2007
Change of Director's Interest Notice Dec 6, 2007
Appendix 3B Issue of Options Dec 6, 2007
Change of Director's Interest Notice Dec 5, 2007
Results of Meeting Nov 28, 2007
Chairman's Address to Shareholders Nov 28, 2007
Appendix 3B Exercise of Options Nov 2, 2007
Shareholder acquires Additional Equity Stake Oct 31, 2007
Appendix 3B Loan Conversion Oct 31, 2007
2007 Annual Report Oct 26, 2007
Notice of Annual General Meeting Oct 26, 2007
Appendix 4C - Quarterly Cash Flow Report Oct 26, 2007
Benitec AusBiotech Conference Presentation Oct 23, 2007
Benitec presents at National AusBiotech Conference Oct 23, 2007
Initial Director's Interest Notice Oct 16, 2007
Investor Presentation for US Roadshow Oct 15, 2007
Benitec conducts US roadshow Oct 15, 2007
Benitec appoints Mel Bridges Non-Executive Director Oct 12, 2007
Notice of Initial Substantial Holder Oct 11, 2007
Benitec Investor Presentation Oct-07 Oct 10, 2007
Benitec presents at Intersuisse Asia Pacific LifeScience Forum Oct 10, 2007
US-based Promega Corp acquires additional equity stake Oct 8, 2007
Appendix 3B Conversion of Promissory Note Oct 8, 2007
Benitec at BioPartnering Europe Meeting Oct 8, 2007
Nucleonics petition denied in US Court Oct 5, 2007
Full Year Statutory Accounts 2007 Sep 5, 2007
Preliminary Final Report for Year ended 30 June 2007 Aug 31, 2007
Share Registry Change of Location Aug 30, 2007
Appendix 3B ESOP Options Aug 30, 2007
Benitec appoints Chief Scientific Officer Aug 21, 2007
Benitec MOU with CalbaTech, Inc. Aug 17, 2007
Investor Update Aug 9, 2007
Initial Director's Interest Notice Aug 8, 2007
Patent Reexam and Litigation Update Aug 8, 2007
Commitments Test Entity - Fourth Quarter Report Jul 31, 2007
Benitec wins in US Court Jul 23, 2007
CEO of Benitec joins Board Jul 2, 2007
New Benitec website: better investor communications Jun 27, 2007
Benitec appoints new Scientific Advisory Board Jun 20, 2007
Commences HIV Study in Humans in Los Angeles Jun 13, 2007
Change of Director's Interest Notice x 2 May 14, 2007
Change in substantial holding May 11, 2007
Benitec bio-partnering at BIO2007 May 7, 2007
Benitec features at prestigious Boston meeting May 4, 2007
Commitments Test Entity - Third Quarter Report Apr 30, 2007
London Investor Update Apr 27, 2007
Files US Patent Response Apr 26, 2007
European Patent Update Apr 26, 2007
Investor Update Apr 16, 2007
Change in substantial holding Apr 13, 2007
New CFO Appointed Apr 13, 2007
Change in substantial holding Apr 13, 2007
Completion of Rights Issue & Top 20 Share & Option holders Apr 4, 2007
Phase I Study Update Apr 2, 2007
Becoming a substantial holder Apr 2, 2007
Becoming a substantial holder Apr 2, 2007
Shortfall in Rights Issue Mar 29, 2007
Patent Re-examination Update Mar 16, 2007
Non-Renounceable Issue Mar 5, 2007
Becoming a substantial holder Mar 2, 2007
Half Year Accounts Mar 1, 2007
Half Yearly Report Mar 1, 2007
Preliminary Half Year Report for Period Ending 31 December 2006 Feb 28, 2007
Rights Issue Prospectus Feb 28, 2007
Rights Issue Announcement Feb 26, 2007
Benitec Options Update Feb 26, 2007
Results of General Meeting Feb 21, 2007
Benitec Patent and Litigation Update Feb 13, 2007
Benitec Patent Re-examination Update Feb 6, 2007
Trading Halt Jan 30, 2007
Quarterly Report for Entities admitted on the basis of commitments Jan 30, 2007
Additional Information for General Meeting Jan 8, 2007
Sigma-Aldrich licences Pfizer to use Benitec Technology Jan 5, 2007
Revised Notice of General Meeting Jan 5, 2007
Benitec Receives $650k Investment Support Jan 3, 2007
John Rawling Appointed as Co-Company Secretary and Accountant Jan 3, 2007
Notice of General Meeting Jan 3, 2007
Change in substantial holding Dec 28, 2006
Results of AGM Dec 28, 2006
CEO Presentation Nov 30, 2006
Chairman's Address to Shareholders Nov 30, 2006
Additional Information for AGM Nov 30, 2006
Presentation at AusBiotech National Biotech Conference Nov 30, 2006
Final Annual Report 2006 Oct 31, 2006
Commentary on Benitec Ltd Share Price Oct 31, 2006
Additional Information Re ASX Price Query Oct 30, 2006
Response to ASX Share Price Query Oct 25, 2006
Commitments Test Entity - First Quarter Report Oct 23, 2006
Notice of Annual General Meeting Oct 23, 2006
Reinstatement to Official Quotation Oct 17, 2006
Full Year Statutory Accounts 2006 Oct 17, 2006
Ceasing to be a Substantial Shareholder Oct 11, 2006
Benitec Secures New Investment Support Oct 11, 2006
Benitec Executes New RNAi License Deal with Tacere Therapeutics Oct 10, 2006
Appendix 3B - New Issue Announcement Oct 6, 2006
US-Based Promega Corp Acquires Equity Stake in Benitec Sep 29, 2006
Benitec Update on Audited Accounts Sep 25, 2006
Benitec Accounts Update Sep 14, 2006
Benitec Appoints Paul McMahon as CFO & Company Secretary Sep 14, 2006
Change in substantial holding Sep 11, 2006
Preliminary Final Report Aug 28, 2006
Share Purchase Plan Aug 25, 2006
Benitec Appoints Sue MacLeman as CEO Aug 22, 2006
Benitec Announces Share Purchase Plan Extension Offer Aug 8, 2006
Benitec negotiates reduced CSIRO royalties Aug 8, 2006
Revised Share Purchase Plan Application Form Aug 8, 2006
Revised Shareholder Share Purchase Plan Jul 31, 2006
Share Purchase Plan - Pricing Restructure Jul 26, 2006
Commitments Test Entity - Fourth Quarter Report Jul 26, 2006
Shareholder Share Purchase Plan Jul 26, 2006
Letter to Shareholders Regarding Share Purchase Plan Jun 29, 2006
News Release: Share Purchase Plan Jun 29, 2006
Final Director's Interest Notice - Michael Catelani Jun 22, 2006
Final Director's Interest Notice - Sara Cunningham Jun 22, 2006
Benitec Resumes Manufacturing of HIV/AIDS Therapeutic Jun 5, 2006
Benitec Shuts Down U.S. Operations and Restructures Board
May 25, 2006
Benitec to Present at the American Society of Gene Therapy 9th Annual Meeting May 23, 2006
Benitec Provides Context for Nature Paper on RNAi May 22, 2006
Half Yearly Report Clarification May 10, 2006
Final Director's Interest Notice - Alexander Cappello Apr 28, 2006
New Issue Announcement - Appendix 3B Apr 18, 2006
Commitments Test Entity - Third Quarter Report Apr 18, 2006
Benitec featured on ABC-TV’S Catalyst Apr 17, 2006
Benitec Implements Cost Reductions Apr 11, 2006
Director Resignation - Alex Cappello Apr 4, 2006
Ceasing to be a substantial holder - Barbary Coast Investments
Benitec Featured in BioPharm International Biopartnering Down Under article
Mar 24, 2006
Benitec Announces Appointment of Dr. Mike Dalling to its Board of Directors Mar 24, 2006
Benitec Announces Appointment of Peter Francis as Chairman of the Board of Directors Feb 23, 2006
Benitec Announces Appointment of Company Secretary and Change of Registered Address Feb 23, 2006
Benitec Appoints Two New Directors Feb 8, 2006
Benitec Delays IND Filing for HIV/AIDS Therapeutic Pending Resolution of Manufacturing Result. Jan 30, 2006

 

[back to top]

 
Copyright ©2007. Benitec Ltd. All rights reserved. Disclaimer : Privacy